跳至主要内容
临床试验/IRCT2015022812781N2
IRCT2015022812781N2已完成2 期

Comparison of efficacy of Levetiracetam with Sodium Valproate in the treatment of Chronic Migraine Headache in patients referred to Ahvaz Golestan Hospital

Ahvaz University of Medical Siences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15 years 至 50 years(—)
性别
All

入选标准

  • Patients with chronic migraine headache according to the International Headache Society criteria , (having headache 15 or more days per month with at least 8 days per month fulfilling International Headache Society criteria for migraine for at least 3 months)
  • in the absence of ongoing medication overuse; Women have a negative pregnancy test and have appropriate contraception during the study period; No history of liver disease and kidney; No headaches other than migraine-like headaches included tension headache,sinus headache disorder,structural or post traumatic headache and Exclusion criteria: The incidence of side effects such as gastrointestinal or any other unwanted side effects caused by drug; Do not use the medication in groups for three consecutive days or a week of intermittent.

排除标准

  • 未提供

研究者

发起方
Ahvaz University of Medical Siences

相似试验